Remdesivir (GS-5734)
Remdesivir (development code GS-5734) is an antiviral drug, a novel nucleotide analogue prodrug. It was developed by Gilead sciences as a treatment for Ebola virus disease and Marburg virus infections, though it has subsequently also been found to show reasonable antiviral activity against more distantly related viruses such as respiratory syncytial virus, Junin virus, Lassa fever virus and MERS-coronavirus. There is possible activity against other coronaviruses such as SARS and potentially 2019-nCoV infections.
Customers also viewed :
Product Details
| Category |
API's & Drug Standards Cancer Research and Antivirals |
|---|---|
| Price | 1mg £20 5mg £40 25mg £130 50mg £195 100mg £275 1g POA |
| CAS Number | 1809249-37-3 |
| Formula | C27H35N6O8P |
| Molecular Weight | 605.28 |
| Purity | Min 98% |
| Appearance | White to light yellow powder |
| Availability | In Stock |
| Storage Conditions | +4°C |
| MSDS Data Sheet | Click to download |
| MDL Number | Request if not shown |
| Harmonised Tariff | 29335995 |
Product Enquiry
Send us your enquiry for Remdesivir (GS-5734). We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.
We value your input so if you have suggestions regarding new applications for Remdesivir (GS-5734) email us and we will include your contribution on the website.
